These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30318719)

  • 1. Placental nitric oxide formation and endothelium-dependent vasodilation underlie pravastatin effects against angiogenic imbalance, hypertension in pregnancy and intrauterine growth restriction.
    Chimini JS; Possomato-Vieira JS; da Silva MLS; Dias-Junior CA
    Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):385-393. PubMed ID: 30318719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increases in placental nitric oxide, but not nitric oxide-mediated relaxation, underlie the improvement in placental efficiency and antihypertensive effects of hydrogen sulphide donor in hypertensive pregnancy.
    Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
    Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1118-1127. PubMed ID: 29927503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
    Ren Z; Cui N; Zhu M; Khalil RA
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium hydrosulfide prevents hypertension and increases in vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in hypertensive pregnant rats.
    Possomato-Vieira JS; Gonçalves-Rizzi VH; Graça TU; Nascimento RA; Dias-Junior CA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1325-1332. PubMed ID: 27620880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
    Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin Prevents Increases in Activity of Metalloproteinase-2 and Oxidative Stress, and Enhances Endothelium-Derived Nitric Oxide-Dependent Vasodilation in Gestational Hypertension.
    Toghi CJ; Martins LZ; Pacheco LL; Caetano ESP; Mattos BR; Rizzi E; Dias-Junior CA
    Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.
    Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
    Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R505-21. PubMed ID: 27280428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
    Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
    Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension.
    Bauer AJ; Banek CT; Needham K; Gillham H; Capoccia S; Regal JF; Gilbert JS
    Hypertension; 2013 May; 61(5):1103-10. PubMed ID: 23460290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, augmented activity of matrix metalloproteinases-2 and -9 and angiogenic imbalance in hypertensive pregnancy are attenuated by doxycycline.
    Nascimento RA; Possomato-Vieira JS; Gonçalves-Rizzi VH; Bonacio GF; Rizzi E; Dias-Junior CA
    Eur J Pharmacol; 2018 Dec; 840():60-69. PubMed ID: 30336141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticontractile Effect of Perivascular Adipose Tissue But Not of Endothelium Is Enhanced by Hydrogen Sulfide Stimulation in Hypertensive Pregnant Rat Aortae.
    Souza-Paula E; Polonio LCC; Zochio GP; da Silva KP; Kushima H; Dias-Junior CA
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):715-729. PubMed ID: 32976209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy hypertension-associated endothelial dysfunction is attenuated by isoflurane anesthesia: Evidence of protective effect related to increases in nitric oxide.
    Rodrigues SD; da Silva MLS; Martins LZ; Gomes SEB; Mariani NAP; Silva EJR; Kushima H; Mattos BR; Rizzi E; Dias-Junior CA
    Life Sci; 2023 Oct; 331():122039. PubMed ID: 37648198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both maternal and placental toll-like receptor activation are necessary for the full development of proteinuric hypertension in mice.
    Chatterjee P; Chiasson VL; Kopriva SE; Bounds KR; Newell-Rogers MK; Mitchell BM
    Pregnancy Hypertens; 2018 Jul; 13():154-160. PubMed ID: 30177045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.
    Li W; Mata KM; Mazzuca MQ; Khalil RA
    Biochem Pharmacol; 2014 Jun; 89(3):370-85. PubMed ID: 24704473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy.
    Mazzuca MQ; Li W; Reslan OM; Yu P; Mata KM; Khalil RA
    Hypertension; 2014 Sep; 64(3):632-43. PubMed ID: 24914193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
    Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
    Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.
    Chen J; Ren Z; Zhu M; Khalil RA
    Biochem Pharmacol; 2017 Aug; 138():81-95. PubMed ID: 28506758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.